Dynatronics stock analysis
Want to see DYNTQ full AI Analyst Report?
Dynatronics (DYNTQ) Stock Price & Analysis
DYNTQ Stock Chart & Stats
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- $0.01 - $0.10
- Previous Close
- $0.01
- Volume
- N/A
- Average Volume (3M)
- 41.85K
- Market Cap
- $1,605
- Enterprise Value
- $14.48M
- Total Cash (Recent Filing)
- $761.75K
- Total Debt (Recent Filing)
- $6.90M
- Price to Earnings (P/E)
- 0.0
- Beta
- -0.95
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Recurring Consumables And Installed-base Revenue
Repeat-purchase consumables and accessories create a durable revenue stream tied to the installed base rather than one-off capital sales. This aftermarket revenue promotes customer stickiness, predictable recurring receipts and margin support over multiple quarters, softening volatility from episodic equipment orders.
Specialized Product Portfolio In Physical Therapy And Rehab
A focused product set for physical therapy and rehabilitation builds domain expertise and customer relationships with clinics and providers. Specialized clinical equipment and bundled consumables create barriers to casual competition, enabling durable reseller/distributor ties and repeat purchasing patterns from healthcare customers.
Positive Free Cash Flow To Net Income Ratio
A positive free cash flow to net income ratio indicates the company converts reported losses into some real cash generation efficiency. While overall cash generation is weak, this metric suggests operational cash conversion exists and can support short-term operations or debt servicing if trends stabilize or improve.
Bears Say
Declining Revenue And Shrinking Margins
Sustained revenue decline and contracting gross, EBIT and net margins reduce operating leverage and limit the firm's ability to fund R&D, sales, or service investments. Persistent top-line and margin deterioration undermines long-term competitiveness and makes recovery harder without structural change or cost restructuring.
High Leverage And Weakened Equity Base
A debt-to-equity ratio above 2x combined with negative ROE signals high financing risk and limited equity cushion. Heavy leverage constrains strategic flexibility, increases interest burden during losses, heightens refinancing risk, and raises the chance of covenant pressure or distress if operating performance doesn't improve.
Weak Cash Generation And Liquidity Pressure
Negative free cash flow growth and low operating coverage create sustained liquidity strain, forcing reliance on external financing or asset actions. Over several months this limits investments, heightens default and covenant risk, and reduces ability to fund sales/distribution initiatives necessary to restore growth.
DYNTQ FAQ
What was Dynatronics’s price range in the past 12 months?
What is Dynatronics’s market cap?
When is Dynatronics’s upcoming earnings report date?
How were Dynatronics’s earnings last quarter?
Is Dynatronics overvalued?
Does Dynatronics pay dividends?
What is Dynatronics’s EPS estimate?
How many shares outstanding does Dynatronics have?
What happened to Dynatronics’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Dynatronics?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Dynatronics
Dynatronics Corporation operates as a medical device enterprise, specializing in the development, manufacturing, and distribution of a wide array of products geared towards physical therapy, rehabilitation, orthopedics, pain management, and athletic training, primarily within the United States. Their extensive portfolio of orthopedic soft bracing solutions includes items like cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity support garments, knee immobilizers and stabilizers, ankle walkers and braces, plantar fasciitis splints, and cold therapy products. The company also furnishes therapeutic modality devices, such as electrotherapy units, ultrasound equipment, phototherapy systems, medical lasers, shortwave diathermy machines, radial pulse therapy tools, hot and cold treatment options, compression therapy systems, and various electrodes. Moreover, Dynatronics provides a range of rehabilitation and exercise apparatus, encompassing both powered and manually operated treatment tables, mat platforms, specialized work tables, parallel bars, training stairs, weight racks, treadmills, and other related physical therapy equipment. To round out its offerings, the firm supplies clinical consumables like exercise bands and tubing, topical lotions and gels, supplementary orthopedic bracing products, paper goods, and other essential clinic provisions. Dynatronics markets its products under recognized brands, including Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM. Its customer base is diverse, reaching orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. Additionally, products are sold directly to consumers online. The company extends its reach internationally, exporting its goods to approximately 30 countries. Founded in 1979, Dynatronics Corporation is headquartered in Eagan, Minnesota.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Brian D. Baker
- Employees
- 88
- Website
- www.dynatronics.com
- Address
- 1200 Trapp Road, Eagan, MN, 55121, US
Dynatronics (DYNTQ) Earnings & Revenues
DYNTQ Earnings Call
Earnings Call SentimentNeutral
The earnings call highlighted successful cost reduction efforts and new product launches, which contributed to a decrease in net loss. However, the company faced challenges with decreased net sales and uncertainty regarding new product revenue. The lowered revenue guidance reflects ongoing challenges in demand and customer relationships.
View all DYNTQ earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 1 | 9 |
| Technical Analysis | 5 | 1 | 2 |
| Moving Averages | 3 | 0 | 7 |

